SWX ID CONGOODS PR/ CH0022635277
C3000P30/05/2024 17:40:00 | Chg. +74.2200 | Ouverture | Haut | Bas | Précédent Fermer |
---|---|---|---|---|---|
3,421.4100CHF | +2.22% | 3,337.2000 | 3,434.5700 | 3,336.5300 | 3,347.1900 |
GlobeNewswire
22:13
LED Lighting, EV Charging and Maintenance Solutions Provider Orion Hosts Q4 Call Thurs., June 6th at...
GlobeNewswire
22:12
Caring House Receives $3 Million Challenge Grant for Expansion of Durham Hospitality House
GlobeNewswire
22:10
Collective Audience Receives Additional Nasdaq Notification Regarding Continued Listing Requirements
GlobeNewswire
22:10
Kimco Realty® Management to Present at Nareit’s REITweek: 2024 Investor Conference
GlobeNewswire
22:05
Cytek Biosciences to participate at the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
22:05
IndyCar Driver Marcus Armstrong to Represent Root Insurance at Detroit Grand Prix
GlobeNewswire
22:05
Gyre Pharmaceuticals Receives IND Approval from China’s NMPA to Evaluate F230 for the Treatment of P...
GlobeNewswire
22:05
Larimar Therapeutics Selected by FDA to Participate in START Pilot Program for Nomlabofusp in Friedr...
GlobeNewswire
22:05
Agios to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024
GlobeNewswire
22:05
Oncternal Announces Enrollment Completed and Dosing Initiated for Fifth Dose Cohort of Phase 1/2 Stu...
GlobeNewswire
22:05
Crinetics Pharmaceuticals Appoints Robert M. Cuddihy, M.D., as Senior Vice President of Medical Affa...
GlobeNewswire
22:05
BioSig Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq ...
GlobeNewswire
22:05
NextCure Presents Phase 1b Data on NC410 and Pembrolizumab Combination at ASCO 2024
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page